This summer, results from the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) trial sparked a controversy that is gathering momentum. The results were presented at the annual ...
In a recent phase 2 study, nearly half of patients who had resectable stage 3B/C BRAF V600-mutant melanoma achieved pathologic complete response (pCR) – meaning that no active cancer cells are present ...
“Most controversies would soon be ended, if those engaged in them would first accurately define their terms, and then adhere to their definitions.” In the article that accompanies this editorial, von ...
SAN ANTONIO -- Patients with stage 2 or stage 3 triple-negative breast cancer (TNBC) who had a pathologic complete response (pCR) after presurgery chemotherapy had increased event-free and overall ...
Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback